Rammy S Gold, MD | |
1212 Garfield Ave, Suite 300, Parkersburg, WV 26101-3207 | |
(304) 865-3600 | |
(304) 865-3700 |
Full Name | Rammy S Gold |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1212 Garfield Ave, Parkersburg, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568439172 | NPI | - | NPPES |
0373804 | Medicaid | OH | |
0089219000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 18433 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rammy S Gold, MD 1212 Garfield Ave, Suite 300, Parkersburg, WV 26101-3207 Ph: (304) 865-3600 | Rammy S Gold, MD 1212 Garfield Ave, Suite 300, Parkersburg, WV 26101-3207 Ph: (304) 865-3600 |
News Archive
In an interesting bit of scientific serendipity, researchers at North Carolina State University have found that a chemical compound useful for studying the origins of intestinal birth defects may also inhibit the growth and spread of cancerous tumors.
Molecules that change colour can be used to follow in real-time how bacteria form a protective biofilm around themselves.
Baylor Endocrine Center is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. The project is called the GRADE: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study.
As part of health care reform, the federal government is testing different ways to reward physicians for the quality -; not quantity -; of their services, all in the hope of improving patient care.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
› Verified 9 days ago